BRAIN HEALTH AND FITNESS CLASSES IN OLDER ADULTS WITH PARKINSON’S DISEASE: INITIAL FINDINGS OF A PILOT PROJECT

Author(s): BARDUTZ, H., KAHN, Z., WITTE, K., HA, H., SINGHARATH, A., SHAFIQ, M., SINGH, J., Institution: UNIVERSITY OF REGINA, Country: CANADA, Abstract-ID: 916

INTRODUCTION:
Parkinson’s Disease (PD) involves motor and non-motor conditions which affects day-to-day functioning. Literature suggests a positive influence among educational interventions involving physical activity and specific nutrients on cognitive health and quality of life for individuals with PD. The following study was conducted to evaluate the cost effectiveness and introductory findings related to cognitive health and fitness interventions on cognitive function and feelings of subjective hope.
METHODS:
People with PD participated in an 8-week brain health and fitness intervention with an option to bring a support person. This class taught participants about socialization, nutrition, sleep, stress, and exercise. Each class was tailored to include relevant activities depending on the weekly topic allowing individuals to interact with other participants. People were given the option to participate in research and 3 people with PD choose to participate in the research. Prior to the classes, individuals completed the Montreal Cognitive Assessment (MOCA) and the Adult Hope Scale which they completed again following the conclusion of the 8-week class.
RESULTS:
The three people successfully finished the entire 8-week course intervention and pre- and post- assessments with no complaints about the length of the course nor the requirements of the study. After the course, three participants performed either equally or better on both the Hope and Moca tests.
CONCLUSION:
The Brain Health and Fitness classes can be effectively completed for research purposes in the Parkinson’s population, with the methods being feasible for the participants to complete and understand. Adherence remained high, suggesting good feasibility. Future research will include larger sample sizes, including those with Parkinson’s Disease and other neurological conditions and in the general population.